Get comprehensive COL11A2 Gene Deafness Autosomal Dominant Type 13 NGS Genetic DNA Test for $500 USD in USA. Advanced next-generation sequencing detects hereditary hearing loss mutations. Available in New York
Get comprehensive COL4A3 Gene Alport Syndrome Autosomal Recessive NGS Genetic DNA Test for $500 in USA. Advanced NGS technology detects inherited kidney disease risk. Available in New York COL4A3 Gene Alport Syndrome Autosomal Recessive Genetic Test Original price was: $700.Current price is: $500.
Get comprehensive GJB3 Gene Deafness Autosomal Recessive NGS Genetic DNA Test for $500 in USA. Advanced hereditary hearing loss screening available in New York GJB3 Gene Deafness Autosomal Recessive Genetic Test Original price was: $700.Current price is: $500.
Sale!

COL11A2 Gene Deafness Autosomal Dominant Type 13 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The COL11A2 Gene Deafness Autosomal Dominant Type 13 NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the COL11A2 gene responsible for hereditary hearing loss. Using next-generation sequencing technology, this test provides comprehensive detection of pathogenic variants associated with autosomal dominant nonsyndromic hearing loss. Individuals experiencing progressive hearing impairment, those with family history of genetic deafness, or couples planning pregnancy should consider this test. The analysis offers crucial information for early intervention, treatment planning, and genetic counseling. Results are typically available within 3-4 weeks from blood or DNA samples. This essential genetic screening costs $500 USD and provides valuable insights for managing hereditary hearing conditions and making informed family planning decisions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

COL11A2 Gene Deafness Autosomal Dominant Type 13 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Hereditary Hearing Loss

The COL11A2 Gene Deafness Autosomal Dominant Type 13 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for hereditary hearing disorders. This advanced testing methodology utilizes next-generation sequencing (NGS) technology to identify specific mutations in the COL11A2 gene, which plays a critical role in collagen formation within the inner ear structures. Early detection through this comprehensive genetic analysis enables proactive management strategies and informed decision-making for individuals and families affected by genetic hearing loss.

What This Test Measures and Detects

This sophisticated genetic test specifically targets the COL11A2 gene located on chromosome 6, which encodes the alpha-2 chain of type XI collagen. The test identifies:

  • Pathogenic variants and mutations in the COL11A2 gene
  • Single nucleotide polymorphisms (SNPs) associated with hearing loss
  • Copy number variations affecting collagen production
  • Specific genetic markers for autosomal dominant nonsyndromic hearing loss
  • Inheritance patterns and carrier status information

Who Should Consider This Genetic Test

This comprehensive genetic screening is recommended for individuals experiencing:

  • Progressive hearing loss beginning in childhood or early adulthood
  • Family history of hereditary hearing impairment
  • Unexplained sensorineural hearing loss
  • Planning pregnancy with concerns about genetic hearing conditions
  • Children with delayed speech development due to hearing issues
  • Individuals with collagen-related connective tissue disorders

Significant Benefits of Genetic Testing

Undergoing the COL11A2 genetic test provides numerous advantages:

  • Accurate Diagnosis: Precise identification of the genetic cause of hearing loss
  • Early Intervention: Enables timely treatment and management strategies
  • Family Planning Guidance: Provides crucial information for reproductive decisions
  • Personalized Treatment: Helps tailor hearing rehabilitation approaches
  • Genetic Counseling: Supports informed family discussions about inheritance risks
  • Peace of Mind: Reduces uncertainty about the cause of hearing impairment

Understanding Your Test Results

Your genetic test results will be thoroughly explained by our certified genetic counselors:

  • Positive Result: Indicates the presence of a pathogenic COL11A2 mutation, confirming genetic hearing loss diagnosis
  • Negative Result: Suggests that COL11A2 mutations are not the cause of hearing loss, though other genetic factors may be involved
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
  • Carrier Status: Determines if you carry one copy of a mutated gene that could be passed to offspring

Test Pricing Information

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art laboratories ensure accurate and reliable results with a standard turnaround time of 3-4 weeks.

Take Control of Your Genetic Health Today

Don’t let uncertainty about hereditary hearing loss affect your quality of life. Our experienced genetic specialists and ENT doctors are ready to provide comprehensive testing and counseling services. Schedule your COL11A2 genetic test today to gain valuable insights into your hearing health and make informed decisions for your future.

Call or WhatsApp us now at +1(267) 388-9828 to book your appointment or request more information about this essential genetic screening.

SKU: 4059 Category:

Related products